ONCE-WEEKLY SOMAPACITAN AS AN ALTERNATIVE MANAGEMENT OF GROWTH HORMONE DEFICI…
Growth hormone treatment has effectively restored normal growth in children with growth
hormone deficiency (GHD); however, it poses challenges in compliance with a daily growth hormone
injection regimen, leading to low adherence and persistence rates. Once-weekly Somapacitan is
a potential alternative for treating children with GHD. This study aimed to evaluate the efficacy,
safety, and adherence of once-weekly subcutaneous Somapacitan compared to daily growth hormone
injection in prepub…